Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: A randomized controlled trial

AIDS Research and Human Retroviruses

Volumn 24, Issue 1, 2008, Pages 15-23

  Mutimura, Eugene ^a,b   Crowther, Nigel J ^c   Cade, Todd W ^c   Yarasheski, Kevin E ^b   Stewart, Aimee ^a,b  

^a UNIVERSITY OF RWANDA   (Rwanda)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CHOLESTEROL; EFAVIRENZ; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMIVUDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEVIRAPINE; STAVUDINE; TRIACYLGLYCEROL; ZIDOVUDINE;

ABDOMINAL OBESITY; ADAPTATION; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIORESPIRATORY EXERCISE TRAINING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; EXERCISE; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RWANDA; SAFETY; SKINFOLD THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; CHOLESTEROL; EXERCISE; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHYSICAL ENDURANCE; RWANDA; TREATMENT OUTCOME; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 38149109998     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0023     Document Type: Article

References (44)

1. Chen D, Mistra A, and Garg A: Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2002;87:4845-4856.
2. Lichtenstein KA, Ward DJ, and Moorman AC: Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001;15:1389-1398.
3. Miller J, Carr A, Emery S, et al.: HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia. HIV Med 2003;4:293-301.
4. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, and Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease inhibitor associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet 1999;353:2093-2099.
5. Sterne JA, Herman MA, Ledergerber B, et al.: Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. Lancet 2005;366:378-384.
6. Dolan SE, Hadigan C, Killilea KM, et al.: Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr 2005;39:44-54.
7. Grover SA, Coupal L, Gilmore N, and Mukherjee J: Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol 2005;95:586-591.
8. Hadigan C, Meigs JB, Wilsonn PW, et al.: Prediction of coronary heart disease in HIV-infected patients with fat redistribution. Clin Infect Dis 2003;36:909-916.
9. Bergersen BM, Sandvik L, Bruun JN, and Tonstad S: Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: Results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis 2004;23:625-630.
10. Pujari SN, Dravid A, and Naik E, et al.: Lipodystrophy and dyslipidaemia among patients taking first-line, World Health Organisation-recommended highly active antiretroviral therapy regimens in Western India. J Acquir Immune Defic Syndr 2005;39:199-202.
11. Mutimura E, Stewart A, and Crowther NJ: The prevalence and metabolic consequences of antiretroviral-associated lipodystrophy in a population of HIV-infected African subjects. In: Program and Abstracts (Abstract #28) of the 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 24-26 September, San Francisco, CA. Antiviral Ther 2006;11:L20.
12. Egger M, May M, Chene G, et al.: Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002;360:119-129.
13. Gayle HD: Expanding access to HIV prevention. AIDS Res Ther 2006;3:2.
14. Sterne JA, Herman MA, Ledergerber B, et al.: Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. Lancet 2005;366:378-384.
15. Kengne AP, Amoah AG, and Mbanya JC: Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 2005;112:3592-3601.
16. Hayashi Y, Nagasaka S, Takahashi N, et al.: A single bout of exercise at higher intensity enhances glucose effectiveness in sedentary men. J Clin Endocrinol Metab 2005;90:4035-4040.
17. Katzmarzyk PT, Leon AS, Wilmore JH, et al.: Targeting the metabolic syndrome with exercise: Evidence from the HERITAGE Family Study. Med Sci Sports Exerc 2003;35:1703-1709.
18. Watt K, Beye P, Siafarikas A, et al.: Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol 2004;43:1823-1827.
19. Stewart KJ: Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: Plausible mechanisms for improving cardiovascular health. JAMA 2002;288:1622-1631.
20. Dube MP, Stein JH, Aberg JA, et al.: Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003;37:613-627.
21. Roubenoff R: A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 1999;13:1373-1375.
22. Jones SP, Doran D, Leatt PB, Maher B, and Pirmohamed M: Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS 2001;15:2049-2051.
23. Yarasheski KE, Tebas P, Stanerson B, et al.: Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with anti-retroviral therapy. J Appl Physiol 2001;90:133-138.
24. Roubenoff R, Schmitz H, Bairos L, et al.: Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: Case report and proof of principle. Clin Infect Dis 2002;34:390-393.
25. Scevola D, Di Matteo A, Lanzarini P, et al.: Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003;17:123-129.
26. Driscoll SD, Meininger GE, Lareau MT, et al.: Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004;18:465-473.
27. Fitch K, Anderson EJ, Hubbard JL, et al.: Effects of a lifestyle modification program in HIV-infected patients with metabolic syndrome. AIDS 2006;20:1843-1850.
28. Carr A, Emery S, Law M, et al.: An objective case definition of lipodystrophy in HIV-infected adults: A case-control study. Lancet 2003;361:726-735.
29. Bairaktari E, Hatzidimou K, Tzallas C, et al.: Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 2000;33:549-555.
30. Durnin JVGA and Rahaman MM: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681-689.
31. Durnin JVGA and Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16-72 years. Br J Nutr 1974;32:77-97.
32. Zillikens MC, Conway JM: Anthropometry in blacks: Applicability of generalized skinfold equations and differences in fat patterning between blacks and whites. Am J Clin Nutr 1990;52:45-51.
33. Wilkinson DM, Fallowfield JL, Myers SD: A modified incremental shuttle run test for the determination of peak shuttle running speed and the prediction of maximal oxygen uptake. J Sports Sci 1999;17:413-419.
34. Flouris AD, Metsios GS, and Koutedakis Y: Enhancing the efficacy of the 20 m multi-stage run test. Br J Sports Med 2005;39:166-170.
35. Meisinger C, Doring A, Thorand B, Heier M, and Lowel H: Body fat distribution and risk of type 2 diabetes in the general population: Are there differences between men and women? The MONICA/KORA Augburg cohort study. Am J Clin Nutr 2006;84:483-489.
36. Brown T, Wang Z, Chu H, et al.: Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr 2006;43:356-362.
37. Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, and Wanke C: Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis 2005;40:1837-1845.
38. O'Donovan G, Owen A, Bird SR, et al.: Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate-or-high-intensity exercise of equal energy cost. J Appl Physiol 2005;98:1619-1625.
39. Palacios R, Merchante N, Macias J, et al.: Incidence of and risk factors for insulin resistance in treatment-naïve HIV-infected patients 48 weeks after starting highly active antiretroviral therapy. Antiviral Ther 2006;11:529-535.
40. Meininger G, Hadigan C, Rietschel P, and Grinspoon SK: Body composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men. Am J Clin Nutr 2002;76:460-465.
41. Cade WT, Fantry LE, Nabar S, and Keyser RE: Impaired oxygen on-kinetics in persons with the human immunodeficiency virus are not due to highly active antiretroviral therapy. Arch Phys Med Rehabil 2003;84:1831-1838.
42. Stringer WW, Berezovskava M, O'Brien WA, Beck CK, and Casaburi R: The effects of exercise training on aerobic fitness, immune indices, and quality of life in HIV positive patients. Med Sci Sports Exerc 1998;30:11-16.
43. Thöni GJ, Fedou C, Brun JF, et al.: Reduction of fat accumulation and lipid disorders by individualized light aerobic training by human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidaemia. Diabetes Metabol Paris 2002;28:397-404.
44. Carnethon MR, Gulati M, and Greenland P: Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. JAMA 2005;294:2981-2988.